The approval is the 14 th for Keytruda, extending its use into a tenth ... for Opdivo in second-line HCC after it became clear the EMA would not accept the data that backed its US approval.

It was more successful in Europe, where Merck is known as MSD, as the EMA gave the go-ahead for ... application in the US across all of Keytruda’s approved indications in adults, both on its ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Block Inc. said its Square Financial Services industrial bank subsidiary received approval from the US Federal Deposit Insurance Corp. to begin offering consumer loans directly through its Cash ...

ByInvesting.com • Sep 28, 2023 Merck and Eisai Provide Update on Two Phase 3 Trials Evaluating KEYTRUDA Plus LENVIMA ... today announced that the European Medicines Agency’s Committee ...

The trial’s first phase will begin in university hospitals across the Netherlands, Denmark, Germany and Sweden.

FEMA approved Michigan’s request for a federal disaster declaration after a series of floods devastated the Detroit area in August 2023. The disaster declaration allowed residents to apply for ...

“FDA approval of our forthcoming U.S. trials in ... recruited in a combination trial of Alpha DaRT with pembrolizumab (Keytruda), a checkpoint inhibitor, in treating patients with recurrent ...

A pembrolizumab (Keytruda) combination led to an overall survival (OS) boost in patients with newly diagnosed, previously ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today an ...

Norwegian technology firm Pherousa has received approval in principle for its onboard ammonia cracking technology from classification societies American Bureau of Shipping and DNV. The technology ...

Canadian telecommunications firm Mitel Networks won a Texas court’s approval for its debtor-in-possession financing on an interim basis. “It’s just clear to me that there’s no other real options on ...